Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

MSD’s Bold HIV Drug Combo: Could It Be the Future of Treatment?

Daniel Kim Views  

Medical Today
Medical Today

Merck Sharp & Dohme (MSD) recently reported that a combination of two drugs showed promising results in suppressing HIV-1 replication during two late-stage clinical trials.

MSD seeks new growth drivers to offset the potential hit if its blockbuster cancer immunotherapy Keytruda loses patent protection.

MSD’s clinical trial, involving over 1,000 patients, evaluates the efficacy of combining Doravirine and Islatravir.

One study revealed that MSD’s combination therapy demonstrated a better safety profile compared to Gilead’s HIV drug, Biktarvy. However, in patients already receiving Gilead’s medication, the new treatment didn’t surpass Biktarvy’s effectiveness in suppressing HIV-1, the most prevalent HIV strain.

Meanwhile, MSD intends to submit the clinical trial data to regulatory authorities and present detailed findings at an upcoming conference.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LIFESTYLE] Latest Stories

  • Pilates: The Low-Impact Workout with Big Benefits for Your Body and Mind
  • Are Your Favorite Foods Actually Aging You? The Truth About Glycotoxins
  • Best Workouts for Your Knees: Keeping Arthritis at Bay
  • Are Probiotics Overrated? Experts Urge Caution Over Gut Health Claims
  • 5 Unexpected Benefits of Chewing Gum
  • Sugar-Free Doesn't Always Mean Safe: Health Risks of Zero-Calorie Sodas

You May Also Like

  • 1
    ID.EVERY1: Volkswagen's $21K Electric Vehicle Aims to Make Green Driving Accessible

    BUSINESS 

  • 2
    Toyota’s bZ3X SUV Surges with 10,000 Pre-Orders: A New Era in EVs

    BUSINESS 

  • 3
    Telo Trucks' MT1: A 500-HP Compact Pickup That Packs Big Punch in a Small Frame

    BUSINESS 

  • 4
    Xiaomi’s Success vs. Apple’s Failure: What’s the Difference?

    DEBATE 

  • 5
    Mitsubishi Delica D:2 Facelift: New Design, Better Fuel Economy, and Enhanced Safety

    BUSINESS 

Popular Now

  • 1
    Major Vehicle Recall: Over 15,000 Cars Affected Across Multiple Brands in South Korea

    BUSINESS&nbsp

  • 2
    Blazer EV SS Hits New Highs: 615 Horsepower and 3.4-Second 0-60 Acceleration

    BUSINESS&nbsp

  • 3
    Trump Defends Tesla, Promises Action Against Violent Attacks

    DEBATE&nbsp

  • 4
    Land Rover’s New Defender 130: Luxury Meets Off-Road Performance in a Seven-Seater

    BUSINESS&nbsp

  • 5
    Honda's New NSX Successor: 1,000 HP Electric Supercar Expected by 2027

    BUSINESS&nbsp

Must-Reads

  • 1
    ID.EVERY1: Volkswagen's $21K Electric Vehicle Aims to Make Green Driving Accessible

    BUSINESS 

  • 2
    Toyota’s bZ3X SUV Surges with 10,000 Pre-Orders: A New Era in EVs

    BUSINESS 

  • 3
    Telo Trucks' MT1: A 500-HP Compact Pickup That Packs Big Punch in a Small Frame

    BUSINESS 

  • 4
    Xiaomi’s Success vs. Apple’s Failure: What’s the Difference?

    DEBATE 

  • 5
    Mitsubishi Delica D:2 Facelift: New Design, Better Fuel Economy, and Enhanced Safety

    BUSINESS 

Popular Now

  • 1
    Major Vehicle Recall: Over 15,000 Cars Affected Across Multiple Brands in South Korea

    BUSINESS 

  • 2
    Blazer EV SS Hits New Highs: 615 Horsepower and 3.4-Second 0-60 Acceleration

    BUSINESS 

  • 3
    Trump Defends Tesla, Promises Action Against Violent Attacks

    DEBATE 

  • 4
    Land Rover’s New Defender 130: Luxury Meets Off-Road Performance in a Seven-Seater

    BUSINESS 

  • 5
    Honda's New NSX Successor: 1,000 HP Electric Supercar Expected by 2027

    BUSINESS